These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29397911)

  • 1. Feasibility of a streamlined imaging protocol in technetium-99m-Tektrotyd somatostatin receptor SPECT/CT.
    Al-Chalabi H; Cook A; Ellis C; Patel CN; Scarsbrook AF
    Clin Radiol; 2018 Jun; 73(6):527-534. PubMed ID: 29397911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental value of
    Trogrlic M; Težak S
    Nuklearmedizin; 2017 Jun; 56(3):97-107. PubMed ID: 28164207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of SPECT-CT with 99mTc-Tektrotyd in bronchial and thymic neuroendocrine tumors (NETs).
    Sergieva S; Robev B; Dimcheva M; Fakirova A; Hristoskova R
    Nucl Med Rev Cent East Eur; 2016; 19(2):81-7. PubMed ID: 27479885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.
    Madrzak D; Mikołajczak R; Kamiński G
    Nucl Med Rev Cent East Eur; 2016; 19(2):88-92. PubMed ID: 27479886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological Uptake in the Pancreatic Head on Somatostatin Receptor Scintigraphy Using [111In-DTPA]Octreotide: Incidence and Mechanism.
    Brabander T; Teunissen J; Kwekkeboom D
    Clin Nucl Med; 2017 Jan; 42(1):15-19. PubMed ID: 27775943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image fusion analysis of (99m)Tc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours.
    Gabriel M; Hausler F; Bale R; Moncayo R; Decristoforo C; Kovacs P; Virgolini I
    Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1440-51. PubMed ID: 16133384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of standardized uptake values (SUV) of metastatic bone lesions in scintigraphy with [99mTc]Tc-EDDA/HYNIC-Tyr3-octreotide in patients with neuroendocrine tumours.
    Malarz MM; Birkenfeld B; Piwowarska-Bilska H
    Nucl Med Rev Cent East Eur; 2024; 27(0):31-35. PubMed ID: 39162352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of
    Xu J; Li Y; Xu X; Zhang J; Zhang Y; Yu X; Huang D
    Ann Nucl Med; 2018 Aug; 32(7):446-452. PubMed ID: 29926342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake in the pancreatic uncinate process on the 111In-octreotide scintigraphy: How to distinguish physiological from pathological uptake?
    Ait Boudaoud A; Verges B; Petit JM; Tatulashvili S; Cochet A; Humbert O
    Nucl Med Commun; 2017 Sep; 38(9):737-743. PubMed ID: 28704340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of
    Chen H; Li Y; Gao X; Shen X
    Clin Imaging; 2018; 52():365-369. PubMed ID: 30248495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial direct comparison of 99mTc-TOC and 99mTc-TATE in identifying sites of disease in patients with proven GEP NETs.
    Cwikla JB; Mikolajczak R; Pawlak D; Buscombe JR; Nasierowska-Guttmejer A; Bator A; Maecke HR; Walecki J
    J Nucl Med; 2008 Jul; 49(7):1060-5. PubMed ID: 18552141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical value of scintigraphy of neuroendocrine tumors using (99m)Tc-HYNIC-TOC.
    Artiko V; Sobic-Saranovic D; Pavlovic S; Petrovic M; Zuvela M; Antic A; Matic S; Odalovic S; Petrovic N; Milovanovic A; Obradovic V
    J BUON; 2012; 17(3):537-42. PubMed ID: 23033296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of 99mTc EDDA/HYNIC-TOC (Tektrotyd) physiological and neuroendocrine tumour uptake using SPECT/CT standardised uptake values: initial experience.
    Reilly C; Gemmell AJ; McLaughlin IM; Fleming R; Reed N; McIntosh D; Nicol A
    Nucl Med Commun; 2021 Aug; 42(8):935-939. PubMed ID: 33741866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99mTc-HYNIC-TOC imaging in the evaluation of pancreatic masses which are potential neuroendocrine tumors.
    Qiao Z; Zhang J; Jin X; Huo L; Zhu Z; Xing H; Li F
    Clin Nucl Med; 2015 May; 40(5):397-400. PubMed ID: 25706799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-specific radiation dosimetry of 99mTc-HYNIC-Tyr3-octreotide in neuroendocrine tumors.
    Grimes J; Celler A; Birkenfeld B; Shcherbinin S; Listewnik MH; Piwowarska-Bilska H; Mikolajczak R; Zorga P
    J Nucl Med; 2011 Sep; 52(9):1474-81. PubMed ID: 21795364
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Briganti V; Cuccurullo V; Berti V; Di Stasio GD; Linguanti F; Mungai F; Mansi L
    Curr Radiopharm; 2020; 13(3):166-176. PubMed ID: 31886756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99mTc-HYNIC-TOC increased uptake can mimic malignancy in the pancreas uncinate process at somatostatin receptor SPECT/CT.
    Yamaga LY; Neto GC; da Cunha ML; Osawa A; Oliveira JC; Fonseca RQ; Nogueira SA; Wagner J; Funari MG
    Radiol Med; 2016 Mar; 121(3):225-8. PubMed ID: 26558391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of 111In-DTPA-octreotide SPECT/CT fusion images in the management of neuroendocrine tumours.
    Castaldi P; Rufini V; Treglia G; Bruno I; Perotti G; Stifano G; Barbaro B; Giordano A
    Radiol Med; 2008 Oct; 113(7):1056-67. PubMed ID: 18797822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc-EDDA/HYNIC-TOC in management of patients with head and neck somatostatin receptor positive tumors.
    Trogrlic M; Tezak S
    Nucl Med Rev Cent East Eur; 2016; 19(2):74-80. PubMed ID: 27479884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99mTc-EDDA/HYNIC-Tyr(3)-octreotide for staging and follow-up of patients with neuroendocrine gastro-entero-pancreatic tumors.
    Gabriel M; Muehllechner P; Decristoforo C; von Guggenberg E; Kendler D; Prommegger R; Profanter C; Moncayo R; Virgolini I
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):237-44. PubMed ID: 16172569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.